The Tylenol Autism and ADHD Lawsuits are class action lawsuits filed in the United States District Court for the Southern District of New York. The Tylenol lawsuits allege that Johnson & Johnson, the makers of Tylenol, failed to warn consumers about potential risks associated with taking acetaminophen during pregnancy and its possible link to autism spectrum disorder (ASD) and other developmental disorders in children including severe ADHD.
Contact Us for a Free Tylenol Autism ADHD Case Evaluation
The Marin and Barrett Law Firm is currently pursuing Tylenol autism lawsuits on behalf of parents or guardians of children with autism (ASD) or Attention-deficit/hyperactivity disorder (ADHD) after prenatal exposure to Tylenol or generic acetaminophen. Contact us today (888) 348-2735 for a free, no obligation claim evaluation or complete our our contact form to receive a call or email at your convenience and around your schedule. While there is no definitive scientific evidence linking acetaminophen use during pregnancy to an increased risk of autism spectrum disorder, recent studies have suggested a possible association between prenatal exposure to certain medications like acetaminophen and an increased risk of ASD and ADHD.
The growing number of mass tort Tylenol autism lawsuits has recently prompted the consolidation of new multi-district litigation of all Tylenol autism lawsuits from around the country before Judge Denise L. Cote in the United States District Court for the Southern District of New York. Judge Denise Cote’s recent ruling in the Tylenol Autism litigation will allow this litigation to move forward in the multi-district litigation. Call today to speak with our Tylenol Autism lawyers for a free, no obligation legal consultation or complete our contact form.
Join the litigation by filing a Tylenol Autism and ADHD Lawsuit Today
Our Tylenol injury attorneys are pursuing mass tort lawsuits for children who were diagnosed with Autism (ASD) or attention deficit / hyperactivity disorder (ADHD) after being exposed to increased levels of acetaminophen (Tylenol) in the womb. Newly released scientific evidence over the last two years has shown a correlation of increased levels of acetaminophen in cord blood samples and umbilical cord blood from newborns, the generic name for the over the counter pain reliever Tylenol, were roughly three times more likely to be diagnosed with ADHD or autism spectrum disorder (ASD) later in childhood, compared to children with the lowest levels of acetaminophen in their cord blood.
Scientific studies from researchers at the Johns Hopkins Bloomberg School of Public Health. The Johns Hopkins University researchers analyzed data from pairs of mothers and children in the Boston Birth Cohort, a 20-year study of early life factors influencing pregnancy and child development.
While the drug makers and Johnson and Johnson continue to dispute the legal basis of the cases that are being filed against them, the Marin and Barrett law firm stands ready to join the controversy by suing to obtain justice in the court of law for your child. If you think your child’s Autism diagnosis or attention deficit hyperactivity diagnosis may be due to exposure to over the counter drug acetaminophen or Tylenol during pregnancy, take legal action today and contact the Tylenol autism injury attorneys at Marin and Barrett, Inc. today for a free case evaluation and join the litigation. Our Tylenol autism lawyers are available 24/7 at (888) 348-2735 to take your call and stand ready to fight for you and your child. We believe that the manufacturers and retailers of Tylenol and acetaminophen should have warned the public of the dangers of its product and the risk of autism when used by pregnant women. If they had properly warned of the risk of autism if taking acetaminophen during pregnancy may have allowed them to take precautionary actions.
Is the Tylenol and Acetaminophen Autism ADHD Lawsuit Real?
Yes, parents whose children have been diagnosed with autism or severe ADHD are pursuing legal mass tort claims by filing Tylenol lawsuits alleging that the use of Tylenol or acetaminophen products during their pregnancy caused their child to develop autism spectrum disorder, severe ADHD, neurodevelopmental disorders, neurological disorders, developmental disorders, defiant disorder and other mental health effects. The Tylenol manufacturers are being sued for negligently failing to warn about the likelihood of autism after usage during pregnancy. The lawsuits seek financial compensation on behalf of ADHD and autistic children for the permanent disability caused by prenatal exposure to different brands of acetaminophen during important periods of fetal brain development.
The focus of these lawsuits has been on the use of the over-the-counter medication acetaminophen, commonly known as Tylenol (the brand name), during pregnancy. Brand name acetaminophen, is known as Tylenol, is manufactured by Johnson & Johnson. Johnson and Johnson owns the rights to the active ingredient list through an acquisition of the original company in 1958. Recently, many retailers such as Walmart and CVS have developed generic acetaminophen products of their own through other manufacturers. Other generic retailers of acetaminophen being sued in this litigationinclude Safeway, Walmart, Target, CVS, Walgreens, Costco, Rite Aid, Sam’s Club, Dollar Tree, and Kroger.
Other acetaminophen drug manufacturers who have been included in the acetaminophen dangerous drug lawsuits include LNK, International, Inc., Perrigo Company plc, Ohm, Laboratories, Inc., Aurobindo Pharma Ltd., Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd., Elysium Pharmaceutical Ltd., Medgel Private Ltd., Aurohealth LLC, AptaPharma Inc., APL Healthcare, Ltd., Hi-Tech Nutraceuticals, LLC, and Johnson and Johnson Consumer Inc.
Tylenol and Autism ADHD Lawsuits Updates
November 15, 2022 Update: In a major early victory for the Plaintiffs in the Tylenol Autism ADHD lawsuits, United States District Court Judge Denise Cote denied Walmart’s motion to dismiss claims against it’s generic version of Tylenol called Equate. Judge Cote determined that federal law, including FDA regulation of labeling of Tylenol, did not prevent or preement a State law Tylenol lawsuit alleging the warning labels on Tylenol and generic acetaminophen products were insufficient to warn pregnant women of the risk of autism and ADHD. The Federal Court ruling brings renewed momentum to the Tylenol Autism ADHD lawsuit and a more positive outlook on the future of this litigation.
November 14, 2022 Update: A status conference on the Tylenol class action MDL will be held on Thursday, November 17, 2022. From what we understand the judge overseeing the case, Judge Denise Cote, will be expected to name her selections for the Tylenol autism lawyers plaintiffs leadership committee and to outline the pretrial proceedings by establishing a discovery plan and tentatively scheduling the trial dates for the product liability claims bellwether trials.
November 13, 2022 Update: Walmart filed a motion to dismiss the Equate (Walmart’s brand Acetaminophen) lawsuit that two plaintiffs have filed out of Arkansas against them on the basis of federal preemption. The class action against alleges that Walmart under state law failed to warn about the risk of taking its Equate-brand Acetaminophen during pregnancy. In the motion to dismiss, Walmart argued that the warning labels on these products are mandated by the FDA under federal law, and that they couldn’t change the labels. The Plaintiffs have responded that FDA regulations never prevented them from making changes to the warning labels to express the risk of the pain reliever to those who are pregnant.
November 8, 2022 Update: While Johnson & Johnson has not been named yet in lawsuit, it does look like several retailers will be. A Tylenol ADHD and autism class action lawsuit was approved by a judge this week to help guide the structure of the defense counsel committee. A “Retailer Liaison Committee” (RLC) will also be formed within the structure that will serve as a liaison between the plaintiffs and the lawyers defending the selected retailers.
October 5, 2022 Update: The Judicial Panel on Multidistrict Litigation has certified a class action lawsuit in New York that will house all Tylenol lawsuits filed in any federal court in the U.S. The Tylenol multidistrict litigation was established after the JPML found there were a large number of lawsuits filed against the manufacturer of Tylenol alleging a link between Tylenol and autism and ADHD. The purpose of the creation of the Tylenol MDL is to streamline the pretrial proceedings in the litigation process and to avoid duplicative or conflicting rulings in different courts.
The creation of an MDL can be beneficial for both plaintiffs and defendants, as it allows for more efficient and cost-effective resolution of the cases. For plaintiffs, an MDL can provide a more convenient forum for their cases because the cases will all be heard by a single judge and allow for coordinated discovery with other similar cases. For defendants, an MDL can help to minimize the costs and risks associated with litigating a large number of similar cases in multiple courts across the country.
Projected Tylenol Autism ADHD Settlement Amounts
At this point in time, it is nearly impossible to provide a specific projection for Tylenol Autism or ADHD settlement amounts as these lawsuits are still in the very early stages of the discovery process. Any future potential settlement amounts for the Tylenol autism lawsuits will depend on a number of factors, including the specific details of each case, the strength of the evidence for each plaintiff, and the negotiating skills and experience of the lawyers involved.
Settlement amounts in product liability cases, including Tylenol autism and ADHD cases, can vary widely. Some settlements may be for a few thousand dollars, while others can be for millions of dollars. The amount of a settlement will depend on a number of factors including the severity of the injury, the impact on the individual’s quality of life, and the costs associated with past and future medical treatment.
It’s important to note that settlement negotiations in Tylenol autism and ADHD cases may be confidential and the terms of the settlement are not typically made public. As a result, it’s difficult to predict what a settlement amount might be in a specific case. If you are considering filing a Tylenol autism or ADHD lawsuit, it’s important to speak with a team of personal injury attorneys who have experience handling these types of cases and taking on the drug makers and pharmaceutical companies. An attorney can help you understand the settlement process and assist you in negotiating a settlement that is fair and just and work to maximize your financial compensation you receive for your legal claims.
